APA (7th ed.) Citation

V, P., H, T., V, T., R, L., MG, W., J, B., . . . DV, R. (2026). Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial. The New England journal of medicine, 394(7), 635. https://doi.org/10.1056/NEJMoa2512133

Chicago Style (17th ed.) Citation

V, Perkovic, et al. "Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial." The New England Journal of Medicine 394, no. 7 (2026): 635. https://doi.org/10.1056/NEJMoa2512133.

MLA (9th ed.) Citation

V, Perkovic, et al. "Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial." The New England Journal of Medicine, vol. 394, no. 7, 2026, p. 635, https://doi.org/10.1056/NEJMoa2512133.